• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫诱导的小鼠巨噬细胞中白细胞介素-6的表达

Interleukin-6 expression in immunologically elicited murine macrophages.

作者信息

Scales W E, Chensue S W, Kunkel S L

机构信息

Department of Pathology, University of Michigan Medical School, Ann Arbor 48109.

出版信息

Pathobiology. 1992;60(5):289-96. doi: 10.1159/000163737.

DOI:10.1159/000163737
PMID:1472283
Abstract

We report the expression of both interleukin-6 (IL6) messenger RNA and biological activity in complete Freund's adjuvant-elicited peritoneal macrophages (CFA-M phi). IL6 mRNA expression peaked between 4 and 8 h of lipopolysaccharide (LPS) stimulation; biological activity was maximal at approximately 18 h of stimulation. LPS-induced IL6 mRNA was inhibited by treatment with cycloheximide (5 micrograms/ml), implicating the participation of a secondary protein mediator in the induction process, or the dependence upon protein synthesis for receptor ligand interactions. Comparison of CFA-M phi with resident peritoneal macrophages suggests that the elicited cell population makes more IL6 in response to LPS than the resident population on a per cell basis.

摘要

我们报道了在完全弗氏佐剂诱导的腹腔巨噬细胞(CFA-M phi)中白细胞介素-6(IL6)信使核糖核酸(mRNA)的表达及生物活性。脂多糖(LPS)刺激4至8小时期间,IL6 mRNA表达达到峰值;生物活性在刺激约18小时时最大。用环己酰亚胺(5微克/毫升)处理可抑制LPS诱导的IL6 mRNA,这表明在诱导过程中有二级蛋白质介质参与,或者受体配体相互作用依赖蛋白质合成。将CFA-M phi与腹腔常驻巨噬细胞进行比较表明,就单个细胞而言,诱导产生的细胞群体对LPS刺激产生的IL6比常驻细胞群体更多。

相似文献

1
Interleukin-6 expression in immunologically elicited murine macrophages.免疫诱导的小鼠巨噬细胞中白细胞介素-6的表达
Pathobiology. 1992;60(5):289-96. doi: 10.1159/000163737.
2
Aging and eliciting agents: effect on murine peritoneal macrophage monokine bioactivity.衰老与诱导剂:对小鼠腹腔巨噬细胞单核因子生物活性的影响
Exp Gerontol. 1993 Mar-Apr;28(2):145-59. doi: 10.1016/0531-5565(93)90004-w.
3
The effect of adrenalectomy on interleukin-1 release in vitro and in vivo.肾上腺切除术对体内外白细胞介素-1释放的影响。
Br J Pharmacol. 1989 Dec;98(4):1137-42. doi: 10.1111/j.1476-5381.1989.tb12657.x.
4
Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture.体内及培养环境中腹膜巨噬细胞对肿瘤坏死因子和白细胞介素-6的差异表达
Am J Pathol. 1993 Oct;143(4):1121-30.
5
An investigation of the temporal induction of cytokine mRNAs in LPS-challenged thioglycollate-elicited murine peritoneal macrophages using the reverse transcription polymerase chain reaction.利用逆转录聚合酶链反应对脂多糖刺激的巯基乙酸诱导的小鼠腹腔巨噬细胞中细胞因子mRNA的时间诱导情况进行研究。
Inflamm Res. 1997 Feb;46(2):65-71. doi: 10.1007/s000110050078.
6
The expression of interleukin-6 by a rat macrophage-derived cell line.大鼠巨噬细胞衍生细胞系白细胞介素-6的表达
FEBS Lett. 1991 Mar 25;280(2):277-80. doi: 10.1016/0014-5793(91)80311-p.
7
Regulation of IgE antibody production by serum molecules. II. Strain-specificity of the suppressive activity of serum from complete freund's adjuvant-immune low responder mouse donors.
J Immunol. 1978 Jun;120(6):2060-7.
8
Effects of intravenous injection of BCG or Freund's complete adjuvant on swine alveolar macrophages.静脉注射卡介苗或弗氏完全佐剂对猪肺泡巨噬细胞的影响。
Vet Immunol Immunopathol. 1983 May;4(4):459-67. doi: 10.1016/0165-2427(83)90006-5.
9
Differential sensitivity of mouse mononuclear phagocytes to CSF-1 and LPS: the potential in vivo relevance of enhanced IL-6 gene expression.小鼠单核吞噬细胞对集落刺激因子-1和脂多糖的差异敏感性:白细胞介素-6基因表达增强的潜在体内相关性
Cell Immunol. 1996 Dec 15;174(2):165-72. doi: 10.1006/cimm.1996.0306.
10
In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression.小鼠肿瘤坏死因子-α基因表达的体内动力学。地塞米松诱导抑制的动力学。
Lab Invest. 1989 Jun;60(6):766-71.

引用本文的文献

1
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.纤溶酶原激活物抑制剂 1 是一种新型粪便生物标志物,可用于监测炎症性肠病的疾病活动和治疗反应。
J Crohns Colitis. 2024 Mar 1;18(3):392-405. doi: 10.1093/ecco-jcc/jjad160.